Disulfide tethering screening is applied to address the challenge of targeting oncogenic KRAS, historically deemed undruggable due to its high nucleotide affinity and perceived lack of binding sites. Here, the authors developed a disulfide library and a set of 83 cysteine KRAS mutants to perform tethering screens towards the oncogenic KRAS, while describing the discovery of fragment-binding pockets in KRAS G12D, identified by this screening approach.
- Trent E. Balius
- Marcin Dyba
- David M. Turner